Expert Review of Vaccines

Article	Citations
Impact of the Delta variant on vaccine efficacy and response strategies	165
Restoring confidence in vaccines in the COVID-19 era	148
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?	133
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies	125
COVID-19 vaccine: where are we now and where should we go?	103
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination	82
Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases	76
How can a global pandemic affect vaccine hesitancy?	73
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations	63
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China	60
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era	58
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis	56
Army Liposome Formulation (ALF) family of vaccine adjuvants	55
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?	54
ExploringKlebsiella pneumoniaecapsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia	54
COVID-19 vaccines: concerns beyond protective efficacy and safety	53
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China	52
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy	51
Nanovaccine: an emerging strategy	50
Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy	49
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies	48
COVID-19 vaccination in pregnant and lactating women: a systematic review	45
COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa	45
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination	44
Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection	43

Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19	43
Recent advances in human norovirus research and implications for candidate vaccines	42
Social media strategies to affect vaccine acceptance: a systematic literature review	42
Global impact of delta plus variant and vaccination	41
An overview ofin silicovaccine design against different pathogens and cancer	41
Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication	40
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China	39
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update	36
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign	36
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence	32
COVID-19 vaccine equity: a health systems and policy perspective	30
Upper respiratory tract colonization withStreptococcus pneumoniaein adults	29
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials	29
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis	28
Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic	28
The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)	27
Expert review on global real-world vaccine effectiveness against SARS-CoV-2	27
Thermostable vaccines: an innovative concept in vaccine development	26
Vaccine hesitancy in health-care providers in Western countries: a narrative review	26
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?	26
Microneedle Systems for Vaccine Delivery: the story so far	26
Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication	24
Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis	24
Clinical development and approval of COVID-19 vaccines	24
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection	24
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis	24
Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)	23
Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges	23
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome	23
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis	22
The potential impact of COVID-19 pandemic on the immunization performance in Indonesia	22
Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape	22
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways	21
The development of ghost vaccines trials	21
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations	21
Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production	21
COVID-19 and vaccination: myths vs science	20
COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy	20
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns	19
Diabetes mellitus as a vaccine-effect modifier: a review	19
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh	19
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic	19
Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?	19
Progress towards the development of a P. vivax vaccine	18
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years	18
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations	18
Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach	18
Vaccinomics: a future avenue for vaccine development against emerging pathogens	17
Influenza vaccine: progress in a vaccine that elicits a broad immune response	17
The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms	17

Overcoming roadblocks in the development of vaccines for leishmaniasis	17
The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China	17
Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent?	17
Use of lentiviral vectors in vaccination	16
Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines	16
Seasonal influenza vaccine hesitancy profiles and determinants among Chinese children’s guardians and the elderly	16
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy	16
GMMA as a ‘plug and play’ technology to tackle infectious disease to improve global health: context and perspectives for the future	16
An overview of rotavirus vaccination programs in developing countries	16
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China	15
Drivers of hesitancy towards recommended childhood vaccines in African settings: a scoping review of literature from Kenya, Malawi and Ethiopia	15
Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis	15
Ten years of experience with the pneumococcal non-typeableHaemophilus influenzaeprotein D-conjugate vaccine (Synflorix) in children	15
Correlates of malaria vaccine efficacy	15
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?	15
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	15
Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization	15
Eradicating polio in Pakistan: a systematic review of programs and policies	15
Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis	15
Immunoinformatics-guided designing and in silico analysis of epitope-based polyvalent vaccines against multiple strains of human coronavirus (HCoV)	15
The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia	14
Varicella vaccination in Italy and Germany – different routes to success: a systematic review	14
The challenges of a circumsporozoite protein-based malaria vaccine	14
Evaluating the relationship between myocarditis and mRNA vaccination	14
Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect?	14
Vaccine development against methamphetamine drug addiction	14
Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review	14
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease	14
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis	13
Multi-functional antibody profiling for malaria vaccine development and evaluation	13
Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization	13
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy	13
Why METH users are at high risk of fatality due to COVID-19 infection?	13
Recent advances in lipopolysaccharide-based glycoconjugate vaccines	13
Measles, mumps, rubella prevention: how can we do better?	13
Recommendations to drive a value-based decision-making on vaccination	13
Patient decision aid in vaccination: a systematic review of the literature	12
Immune surveillance for vaccine-preventable diseases	12
Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions	12
Challenges targeting cancer neoantigens in 2021: a systematic literature review	12
COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines.	12
Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy	12
Structural vaccinology of malaria transmission-blocking vaccines	12
Immunoinformatics driven construction of multi-epitope vaccine candidate against Ascaris lumbricoides using its entire immunogenic epitopes	12
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review	12
Vaccination strategies between compulsion and incentives. The Italian Green Pass experience	12
Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes	11
Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study	11
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis	11
Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review	11
Vaccine adherence: the rate of hesitancy toward childhood immunization in Kazakhstan	11
Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains	11
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned	11
Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention	11
Progress and new horizons toward a VAR2CSA-based placental malaria vaccine	11
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh	11
COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey	11
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing	10
Vaccines against leishmaniasis: using controlled human infection models to accelerate development	10
How involvement of community pharmacies improves accessibility to and awareness about flu vaccination? – An example from Estonia	10
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis	10
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a revi	10
COVID-19 vaccine design and vaccination strategy for emerging variants	10
Infant vaccine co-administration: review of 18 years of experience with GSK’s hexavalent vaccine co-administered with routine childhood vaccines	10
CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW	10
Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices	10
Prevalence and management of measles susceptibility in healthcare workers in Italy: a systematic review and meta-analysis	10
Combating the great mimicker: latest progress in the development ofBurkholderia pseudomalleivaccines	10
Development of thermostable vaccine adjuvants	10
The race for a COVID-19 vaccine: where are we up to?	10
Impact of a twelve-year rotavirus vaccine program on acute diarrhea mortality and hospitalization in Brazil: 2006-2018	10
Current understandings of the impact of mandatory vaccination laws in Europe	10
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis	10
Monkeypox: a new face of outbreak	10
Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence	9
Additional considerations for anti-tick vaccine research	9
Identifying novel candidates and configurations for human helminth vaccines	9
Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis	9
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data	9
Rotavirus vaccines performance: dynamic interdependence of host, pathogen and environment	9

Immune memory limits human longevity: the role of memory СD4+ T cells in age-related immune abnormalities	9
Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017	9
Modeling tick vaccines: a key tool to improve protection efficacy	9
Vaccination coverage among health-care workers: pre–post intervention study to assess impact of an on-site vaccination-dedicated clinic	9
Self-controlled case series design in vaccine safety: a systematic review	9
Looking to the future: is a universal coronavirus vaccine feasible?	9
An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies	9
Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-2020	9
Synergistic activity of antibodies in the multicomponent 4CMenB vaccine	9
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine	9
The next major emergent infectious disease: reflections on vaccine emergency development strategies	9
An instrument to measure psychosocial determinants of health care professionals’ vaccination behavior: Validation of the Pro-VC-Be questionnaire	9
Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring	9
Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication	9
Improving pandemic preparedness through better, faster influenza vaccines	8
The current and future role of nanovaccines in HIV-1 vaccine development	8
Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?	8
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review	8
Should we be vaccinating children against COVID-19 in high-income countries?	8
Profile of respiratory syncytial virus prefusogenic fusion protein nanoparticle vaccine	8
Thirty years of recombinant BCG: new trends for a centenary vaccine	8
Delays in routine childhood vaccinations and their relationship with parental vaccine hesitancy: a cross-sectional study in Wuxi, China	8
Current development of Zika virus vaccines with special emphasis on virus-like particle technology	8
Efficacy, safety, and formulation issues of the combined vaccines	8
Immune to addiction: how immunotherapies can be used to combat methamphetamine addiction	8
Development of neoantigens: from identification in cancer cells to application in cancer vaccines	8
Bacterial biofilm-derived antigens: a new strategy for vaccine development against infectious diseases	8
Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges	8
Reduced mother-to-child transmission of hepatitis B after implementation of completely charge-free active-passive immunoprophylaxis: an observational cohort study	8
The role of immunoinformatics in the development of T-cell peptide-based vaccines againstMycobacterium tuberculosis	8
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks	8
Effects of the COVID-19 pandemic on routine pediatric vaccination in Brazil	8
Effectiveness of on-site influenza vaccination strategy in Italian healthcare workers: a systematic review and statistical analysis	8
Construction of a multiepitope vaccine candidate againstFasciola hepatica: anin silicodesign using various immunogenic excretory/secretory antigens	7
Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis	7
The associations of geographic location and perceived risk of infection with the intentions to get vaccinated against COVID-19 in China	7
Carbohydrate-containing nanoparticles as vaccine adjuvants	7
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines	7
Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece	7
COVID-19 vaccination and mask wearing behaviors in the United States, August 2020 - June 2021	7
Adverse events following influenza immunization: understanding the role of age and sex interactions	7
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines	7
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2	7
Multi-criteria decision analysis to prioritize the introduction of new vaccines in Indonesia by using the framework of the strategic multi-attribute ranking tool for vaccines (SMART vaccines)	7
‘Vaccinate my village’ strategy in Malawi: an effort to boost COVID-19 vaccination	7
Where are we and how far is there to go in the development of anAcinetobactervaccine?	7
Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)	7
Predicting the risk of severe COVID-19 outcomes in primary care: development and validation of a vulnerability index for equitable allocation of effective vaccines	7
Correlates of protection for meningococcal surface protein vaccines: lessons from the past	7
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK	7
Personalized neoantigen vaccines: a glimmer of hope for glioblastoma	7
A systematic review of vaccine availability at the national, district, and health facility level in the WHO African Region	7
Strategies to increase uptake of maternal pertussis vaccination	7
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers	7
Influence of social media on the public perspectives of the safety of COVID-19 vaccines	7
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?	7
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital	7
Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20	7
Cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis	6
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review	6
The road to achieving herd immunity: factors associated with Singapore residents’ uptake and hesitancy of the COVID-19 vaccination	6
Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment	6
A scoping review of literature exploring factors affecting vaccine uptake within Roma communities across Europe	6
Progress in research on the S protein as the target of COVID-19 vaccines	6
Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada	6
Recent strategies driving oral biologic administration	6
The omics strategy: the use of systems vaccinology to characterize immune responses to childhood immunization	6
COVID-19 vaccines approved in the European Union: current evidence and perspectives	6
Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan	6
Making COVID-19 mRNA vaccines accessible: challenges resolved	6
Harnessing liver-resident memory T cells for protection against malaria	6
Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance	6
Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies	6
Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A	6
Latin American forum on immunization services during the COVID-19 pandemic	6
4CMenB vaccine and its role in preventing transmission and inducing herd immunity	6
Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction	6
Vaccines against SARS-CoV-2 variants and future pandemics	6
Is vaccination necessary for COVID-19 patients? A retrospective cohort study investigating reinfection rates and symptomatology in a tertiary hospital	6
Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs	6
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance	6
Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review	6
Analysis of the coverage of inactivated enterovirus 71 (EV71) vaccine and adverse events following immunization with the EV71 vaccine among children from 2016 to 2019 in Guangzhou	6
Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources	6
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects	6
Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036	6
Development of a recombinant vaccine against human onchocerciasis	5
Parental category B vaccine hesitancy and associated factors in China: an online cross-sectional survey	5
Plasmodiuminfection and drug cure for malaria vaccine development	5
Current regional consensus recommendations on infant vaccination of the Latin American pediatric infectious diseases society (SLIPE)	5
Chlamydia trachomatisvaccine development – a view on the current challenges and how to move forward	5
Research progress in the development of porcine reproductive and respiratory syndrome virus as a viral vector for foreign gene expression and delivery	5
Measuring psychosocial determinants of vaccination behavior in healthcare professionals: validation of the Pro-VC-Be short-form questionnaire	5
Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis	5
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant	5